Amr K. Ahmed1, Yousef S. Albalawi2, Hassan A. Shora3*, Hiba. K. Abdelseed4 and Abdulla N. Al-Kattan5
1Tuberculosis Control Program, Mobile Team, Ministry of Health, Saudi Arabia.
2Medical Hospital Director, Elmam AbdelRahman lfaiasal Hospital, Saudi Arabia.
3Department of Biochemistry, Port-said University, Egypt.
4Tuberculosis Control Program Coordinator, Riaydh Ministry of Health, Saudi Arabia.
5Pharmacology Candidate, Ministry of Health, Saudi Arabia.
*Address for Correspondence: Hassan Shora, Senior Researcher, Port-Said University & Head of Medicine and Diabetes Center, Ismailia General Hospital, Ismailia 064, Egypt. Email: Hassanshora56@gmail.com
Received: 01 August 2020; Accepted: 28 August 2020; Published: 29 August 2020
Citation of this article: Ahmed AK, Albalawi YS, Shora HA, Abdelseed HK, Al-Kattan AN (2020) Effects of Quadruple Therapy: Zinc, Quercetin, Bromelain and Vitamin C on the Clinical Outcomes of Patients Infected with COVID-19. Rea Int J of End and Diabe. 1(1): 018-021. DOI: 10.37179/rijed.000005.
COVID-19 emerged in Wuhan, China in December 2019, reached epidemic proportions, and spread globally as a serious life-threatening pandemic. SARS- Cov-2 is the causative virus that causes severe acute respiratory distress, pneumonia, respiratory failure, and septic shock leading to increased mortality. High risk patients include those with chronic non-communicable diseases such as diabetes, hypertension, coronary heart disease and cancers. No speci????ic treatment is available and supportive care all that could be done to rescue patients. Quadriple therapy consisting of Zinc, Quercetin, Bromelain and Vitamin C showed promising results in improving clinical outcomes among COVID-19 patients.
Keywords: COVID-19, Cytokines, zinc, Quercetin, Bromelain, Vitamin C.